This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Persistent differences in dialysis patient outcomes among Medicare beneficiaries point to the importance of greater quality healthcare access for all. A study by Westat Insight’s Dominick Esposito, Ph.D., and coauthors Andrew Breck, Ph.D., Jeffrey Marr, and Marc Turenne, Ph.D., explored the End-Stage Renal Disease (ESRD) Quality Incentive Program (QIP) and social risk factors to bring varying health outcomes to light.
Published in a recent issue of Medical Care, the article, The Role of Social Risk Factors in Dialysis Quality and Patient Outcomes Under a Medicare Quality Incentive Program, found no evidence of widening health differences in health outcomes in dialysis care or patient outcomes, which is a longstanding and well-publicized concern with value-based purchasing programs.